Anti-Hepatocyte Specific Antigen (HSA)
HSA is used in a panel with CEA (Carcinoembryonic Antigen), Glypican-3, CK7, AFP (Alpha Fetoprotein) and CD10 to aid in the differential diagnosis of hepatocellular carcinoma from cholangiocarcinoma, Hepatoblastomas and/or metastatic adenocarcinoma. Hepatocyte Specific Antigen is also rarely found in gastric carcinomas as well as in a few other non-hepatic tumors.
| Intended Use | IVD |
|---|---|
| Antibody Type | Monoclonal |
| Clone | OCH1E5 |
| Source | Mouse |
| Tissue Type/Cancer Type | Liver Tissue |
| Pack | 0.5 mL – Manual – Concentrate, 1 mL – Manual – Concentrate, 6 mL – Manual – RTU, 50 Tests – Automation – Xmatrx, 50 tests – NanoVIP, 100 Tests – Automation – i6000, 160 Tests – Automation – Xmatrx, 5 slides – Xmatrx, 5 slides – Manual |
